When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KALA - FDA accepts Kala Pharma's refiled application for Eysuvis for dry eye
Kala Pharmaceuticals Inc.
The FDA accepts for review Kala Pharmaceuticals' (NASDAQ:KALA) marketing application seeking approval to use Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% to treat the signs and symptoms of dry eye disease.
More news on: Kala Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,